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I. A NATIONAL LAW ON ABS
-,
Access and benefit sharing (ABS) - definition
'Access' refers to obtaining a country's biological and genetic resources and associated
knowledge. The resource taken is expected to yield benefits through its utilization
especially by commercialisation. 'Benefit-sharing' refers to the sharing of any benefits
derived with the resource provider as a quid pro quo for the access. The benefits could be
monetary (royalties, fees) or non-monetary (technology transfer, knowledge, capacity
building, research results, patents).
CBD: sovereignty of natural resources
The Convention on Biological Diversity (CBD) provides a new paradigm for countries
over their biological and genetic resources. For the first time, an international treaty
recognizes the sovereignty of countries over their natural resources; and gives them the
right to regulate access to these resources and impose conditions for any such access. The
treaty corrects a terrible historical inequity based on the notion that biodiversity,
wherever situate, was the 'heritage of mankind'. Biodiversity was historically accessed
for free from developing countries. Then products often synthesized from this
biodiversity and based on traditional knowledge of its use, were patented and
commercialized. This was almost always done by corporations from countries of the
north. Profits under this unequal and inequitable system flowed to these corporations.
This manner of the misappropriation of resources has been dubbed as 'biopiracy'.
The challenge lies in establishing national regimes that will staunch this misappropriation
while allowing for the conservation and sustainable use of these resources; and for the
fair and equitable sharing with the providers of these resources. Itmust also provide for
the protection of traditional knowledge which has preserved and enhanced biodiversity;
and provides leads for eventual commercial use.
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The value
Diversity has produced crops, medicines, clothing and other useful products for
hum~d ".Crops and forages were cre~ted in farmers fields over millennia and by
research institutes over the last century. This has fed the world. The more distant relatives
of these crops and forages are still growing in the wild. They are another source of
diversity. These genetic resources have been crucial in the past in producing high-
yielding varieties. They are used today in modem breeding, and they will be essential in
the future in feeding the world' growing population.' There are intellectual property
claims over much of the crops developed in modem breeding. The TRIPS agreement of
the WTO mandates member countries to provide protection for plant varieties. Malaysia
like so many other developing countries, has put in place a law to fulfill this obligation.t
Pharmaceutical companies also produce drugs from genetic materials accessed from the
forest and based on leads provided by indigenous peoples and local communities in
developing countries. There was no sharing of benefits either with the country or the
people. This leakage is significant given that at present a large part of existing medicines
in developed countries is derived from natural products collected all over the world.'
Then there is the impetus provided by biotechnology ~ in particular genetic engineering -
whereby biological and genetic resources are marupulated by the insertion of genes
foreign to the species. This coupled with the extension of lP rights over genetic materials
and life forms allowing for claims over the genes, its sequencing and the progeny, and
indeed any product that results from genetic transformation in relation to that resource -
has greatly increased the economic value ascribed to genetic resources and traditional
knowledge.
In part this lP extension over life forms - achieved by the concerted efforts of the
developed countries in securing the revision of the UPOV Convention and the enactment
of the TRIPS Agreement - broadened the gap between the source material and improved
varieties in terms of value and ownership rights attached to them.
The CBD provides an opportunity to restore the balan~e. Its benefit-sharing provisions
assume an importance in the absence of other protecnon frameworks, including lPRs.
Additionally, the CBD n:akes a link between access, benefit sh~g :nd lPRs through the
recognition that the sharing of lPRs can be a form of benefit sharmg.
Developing countries are also relying on the CBD to seek an amendment to the TRIPS
Agreement to deal with biopiracy.
1R th Rao 'Effective Strategies inPGRFA Conservation and Utilisation, inAbstracts Book, National
aman a , dS . bl r r 'Z' . M
Conference on Agrobiodiversity Conservation an ustama e Uti isation, OA
2 New Plant Varieties Act, 2004.
3 See example: Maureen Roubi, 'Rediscovering Natural Products' '. 81/41 Chemical & Engineering News 77
(13 Oct 2003); Gurdial Singh Nijar, In Defence of Local Community Knowledge and Biodiversity, TWN
1996,4-6.
4 Article 16, CBD.
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bThe problems
National level
Malaysia ratified the CBD in 1994. It has adopted various policies for the protection of
biodiversity. These include: the National Diversity Policy in 1998; the National
Biotechnology Policy in 2005; the National Agricultural Policy for 1992 - 2010 and the
National Policy on Domestic Animal Diversity. However there has been no law relating
to the central features of the CBD - that which relates to access to genetic resources and
associated traditional knowledge and the sharing of benefits. This seems also to be the
position in many developing countries.
What has accounted for the lethargy by a large number of developing countries to enact
laws that could, after all, earn benefits? InMalaysia, there was a spirited attempt in the
late 1990s and a task force drafted a law after extensive inter-agency consultations. But
the law was still- born. There were, and are, laws spread over various sectors - forestry,
fisheries, agriculture and so on. But none addresses the issue of ABS. -,
The Constitution distributes power and jurisdiction between the, 13 States and thecentral .'
Federation, Land - on which much of the diversity is Iocated ,~is 'on the State "pst ~cf.
within the jurisdiction of each State. The initiative for a national law has thus far
emanated from the centre. Could this account for the difficulty in promulgating a national
law ABS law? This could well be the case. Yet this problem is not insurmountable. For
example, there is presently a high powered National Council on Biodiversity and
Biotechnology. Its remit js to deal with, the issues.in this area (biodiversity) to ensure
state-federal cooperation. There is precedent for such, cooperation, Tlil·Natlbn.al~'~and',
Code was brought into existenceto provide a single code on land matters to,replace'the'
different state laws. Such a mechanism can be adapted to laws on ABS. Finally Malaysia
has international treaty obligations under the CBD. Treaty-making powers - and the due
national implementation and execution of treaties - are the prerogative of the executive.
Such executive power is clearly in the Federal list. The States of Sarawak and Sabah have
each enacted laws to deal with biodiversity [See appendix 1 of the work of the Sarawak
Biodiversity Centre under the law ' '
• The CBD: these state broad goals and obligations for Parties;
• Any regional law - such as the ASEAN Framework Law on ABS;
• Other national laws that deal with genetic resources: in Malaysia there is the new
Plant Varieties Act 2004.
• Other international efforts to strengthen the efficacy of the national law: such as
the initiatives by developing countries in WTO/ TRIPS, WIPO and the CBD.
The context
A law on access and benefit sharing must take into account its international, regional and
national obligations. These include:
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A. THE KEY PROVISIONS FOR A NATIONAL LAW
This paper identifies and analyses the key provisions that a developing country must
consider for inclusion in a national ABS regime.
1. SCOPE
The following could be considered for inclusion in the scope of the law:
(a) Genetic material
(b) Derivatives
(c) 'Associated TK'
(d) Resources covered by the International Treaty on Plant Genetic Resources for Food and
Agriculture
The further questions to discuss are:
(i) Whether the regulation should differentiate on the basis of the location of
the biological resource?
(ii) Whether there should be a differentiation based on the user of the
resource?
(iii) Whether there should be any exemptions from the scope?
An Elaboration:
(a) Genetic material
The CBD declares the rights of States over their natural resources. In the context of a law
on biological diversity, this term must necessarily mean biological resources. This latter
term is defined in the CBD as 'including genetic resources, organisms or parts thereof,
populations, or any other biotic components of ecosystems with actual or potential use or
value for humanity'. Thus genetic resourc~s. are !Merent in bio!ogical resources and are a
component of these resources. the def1I1ltlOn IS not e~austIve. The term 'including'
suggests that all other matters not covered by the definition can be within the scope of
biological resources.
However the obligation to grant access is confined to 'genetic resources'. 'Genetic
resources' are defined as '...genetic material of actual or potential value'. 'Genetic
material' in turn is defmed as '...any material of plant, animal, microbial or other origin
containing functions of heredity '.
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What does this term 'genetic material' mean?
(i) Any material ofplant, animal, microbial or other origin
Any such material can be the source of genetic material and hence a genetic resource. A
material accessed for its physical properties not for its genetic material will not be a
genetic resource for purposes of the access provision in the CBD. This excludes trees for
their value as timber, plants for their value as food or feed and animals for their food
value. Inmodem breeding, biotechnology - in particular gene-technology - uses genetic
resources within the biological resource more directly. Gene technology is a technology
that transfers genes from one species to another - recombinant-DNA technology. Thus
material of this origin used in gene-technology will be covered by the definition as a
genetic resource.
(ii) '...containingjunctional units of heredity ... '
The material must also contain functional. units of heredity. Genes and promoters fall
within this category. All cells and therefore all biological material contain functional
units of heredity. .' .
(iii) ... of actual orpotential value ... '
Genetic resources that are covered by the access provision must be of actual or potential
. .
value. 'Value' is not defined. It covers a wide use in commori,parlance, It could presently
or potentially be used for food, feed, propagating material, as input for biotechnological
activity, breeding activity, and also have a historic, cultural or ecological value. It may
also have an intrinsic value. Given this wide use value, all genetic resources could be
considered as genetic material. However, insofar as the actual and potential value relates
to the functional units of heredity, this will not cover the use of genetic resource for its
biological properties as food, feed and seeds but only in activities where the functional
units of heredity come into play.5 The defmition of genetic resource then does not cover
for example agricultural products imported for food or feed.
(iv) To sum up this view
Genetic resources are to be understood in the context of the use of biological material.
Biological resources are genetic resources when they are used for the purpose of
exploiting genes or other functional units of heredity; not for use for their physical
properties. The definition of genetic resources excludes the use of biological material
when not used for the purpose of its genes. As an example, a seed used for purpose of
cross breeding or in developing a new variety is used for its genetic resource. It will be
5 Access and Rights to Genetic Resources: a Nordic Approach, Nordic Council of Ministers &Nordic
Council, 2003, pp. 45-49
covered by the provision. But not included is a seed that is sown for harvesting for the
purpose of use as a commodity. So too, a bull is a genetic resource as a source for
fertilizing; not when slaughtered for its meat.
(b) Derivatives
(i) The importance of including
Biological resources are accessed not primarily for their physical properties but for
information of the use as to their chemical constituents, that is derivatives. This may be
the most frequent form of use of a genetic resource. Some of the constituents, once
identified, can be synthetically created in the laboratory. It has been said that if
derivatives are excluded from the scope, most of the potential value and benefits of
adding value to derivatives will be monopolized by large corporations from developed
countries. And indigenous and local communities will become the real losers, since in
developing countries of origin an important part of TK is related to derivatives.f For this
reason the inclusion of derivatives is of considerable importance in an ABS regime. The
value of derivatives, especially in the context of genetic engineering, is underlined by the
fact that biotechnology is defined in Article 2 of the CBD as, ( ...any technological
application that uses biological systems, living organisms, or derivatives thereof, to make
or modify products or processes for specific use '.
Developed countries are arguing strenuously for its exclusion from the scope of the
International regime on ABS now being negotiated under the CBD. The question then
arises: can a national regime legitimately include derivatives within its scope?
6 F d C 'G tic Resources and Property Rights. Tangible and Intangible Property Rights. Theernan 0 asas, ene . .
I f'Deri ti " Record of Discussion InternatIOnalExpert Workshop on Access to Geneticssue 0 enva ves, ill ' .
R d B fit
Sharing Cuemavaca MeXICO,October 24-27,2004, at p. 182.
esources an ene , '
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8(ii) Definition
Derivatives are defined in various ways: as the chemical constituents of a living
organism. or as 'a molecule, or combination or mixture of natural molecules, including
crude extracts of live or dead organisms of biological origin that come from the
metabolism of living beings'; 8 or as extracts from biological and genetic resources such
as blood, oils,resins, genes and seeds, spores, pollen and the like, as well as the products
derived from, patterned on, or incorporating manipulated compounds and/or genes.
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(iii) Article 2 CBD: 'genetic resource' definition includes derivatives
The term 'genetic resources' in the CBD, as noted earlier, includes any genetic resource-
of whatever origin - that contains genes and promoters and which has a present or
potential value and is exploited or accessed for its genetic value. This means that any
material including its constituent elements - derivatives - are covered by the term.
Countries have sovereign rights over these resources and the right to regulate this access.
The grant of access to a specific use of the genetic resource or the derivative does not
give property rights in the property in the derivative or its inherent biochemical
information. .
(iv) In benefit sharing: under CBD
Article 2 of the CBD does not define genetic resources on the basis of its reproductive
functions but on the basis of its composition." All kinds of potential uses of the genetic
resource are included; in particular, the use is not restricted to the reproductive
capabilities of a genetic resource, such as propagation or using isolated genes. Article
15(7) of the CBD provides that there must be sharing through mutually agreed terms
(MAT) of benefits arising from 'the commercial and other utilisation' of genetic
resources. 'Utilization of genetic resources' means the use of any larger or smaller part,
extract or chemical compound from plant, animal, microbial or other origin containing
genes. This includes the use of derivatives. 'Utilization of genetic resources' would
include activities like the production of cosmetics based on the use of plant material, drug
development based on the use of marine microorganisms, and, using isolated genes in
modem biotechnology.
7 Kelly Bannister, 'A Plant Chemist's Perspective on the 'problem' of Derivatives, in Record of Discussion,
International Expert Workshop on Access to Genetic Resources and Benefit Sharing, Cuernavaca, Mexico,
October 24-27,2004, at p. 183.
8 Decision 391, Article 1, of the Andean Community Law.
9 Article 1, ASEAN Framework Agreement on Access to, and Fair and Equitable Sharing of Benefits
arising from the Utilization of, Biological and Genetic Resources (as revised 5 August 2004).
10 The term 'genetic material' is defined by art 2 as any material of plant, animal, microbial or other origin
containing functional units of heredity. This includes all elements that are necessary to establish functional
untis of heredity. This includes genes (including their constituent elements) and the factors that control their
expression and their direct products including RNA and protein. So the term' genetic resource' includes all
things contained in and with the genes: Geoff Burton, 'Discussion Paper: Derivatives', in Record of
Discussion, International Expert Workshop on Access to Genetic Resources and Benefit Sharing,
Cuernavaca, Mexico, October 24-27, 2004, atpp. 185-187.
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(v) In Bonn Guidelines - benefit sharing
Furthe~ the Bonn Guideline~, referred .to by the UN General Assembly, the World
Summit and COP as the basis upon w?ich to ~e:elop an international regime, make it
clear that the access and benefit shanng provisions of a material transfer agreement
inc.lu~e those arising from the use of d.eri~ativ~s of gen~tic resources and their products.'!
This IS based on the fact that the Guidelines mclude III its scope genetic resources and
associated TK and benefits arising from the commercial and other utilization of such
resources. 12
(vi) As apossible element in an International Regime on ABS
Additionally, COP7's terms of reference for the Working Group on the development of
an international regime on ABS - of this more later - requires the issue of derivatives to
be considered as an element in the international regime. 13
(vii) National law may include
In any event, countries can include derivatives in the scope!" of their national ABS law
under Article 3 - broad principle of right to exploit resources, or under Article 15 - right
to regulate access and benefit-sharing. As an example, the ASEAN Framework Law on
ABS requires Parties to include in their ABS laws the disclosure of benefit sharing from
biological and genetic resources 'including benefits from derivatives and products arising
from the commercial and other utilization of such resources. ,15
(viii) Tracking and regulating derivatives in an ABS regime
A concern has been expressed of the difficulty of tracking the flow of derivatives
between laboratories and researchers and its implications for scientific discovery.i" The
problem is presented in these terms. The chemical repertoire of chemical constituents
(derivatives) in plants is vast. After the initial field collection and extraction of plant
compounds, different laboratories specialize in testing of d!fferent medicinal properties.
There is a continuous flow of exchange between laboratones of the test results to save
time and costS.17 Companies often approach researchers in medicinal plant labs for their
testing results. As a result derivatives move quietly and incessantly between labs,
institutions and sometimes countries - through personal or mail delivery. To regulate
these exchanges would require tracking the flow of these materials - from scientists to
11 Bonn Guidelines, D. 44.i, and Appendix I, B.2. .' ...
12 Emphasis added. Bonn Guidelines, C.8. See also the use of this phrase ill C.16.a.l11, and b.ix. DA1, and
DA4.i.
13 Decision VlII19, Annex (d)(xii).
14 See also preceding footnote.
15 Article 6(2)(h). . th' bl ' f'Deri . .
16K 11 B . t 'A Plant Chemist's Perspective on e pro em 0 erivatives, ill Record of
e y anms er, G . R d
D
. . Tnt tional Expert Workshop on Access to enetic esources an Benefit Sharing
lSCUSSlon, erna '
Cuernavaca, Mexico, October 24-27,2004: at p. 183. . . .. ..
17 F I I b may test for anti-vrral propertIes; another for immune-stimulating activity:
or examp e, one a
preceding footnote, at p. 184.
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labs. The implication for an ABS regime is that there must be an effective system for the
labeling and tracking of derivatives taking into account the practical realities of the
generators and users of these derivatives. This could well be a rather difficult task.
An ABS law will have to take these realities into account. When the plant species is first
accessed, then there will be requirement for an access application and the PIC and MAT
with the provider of the genetic resource from whence the derivative emanates. The
agreement can provide that if there is a use developed subsequently that is different from
that shown in the access application, then there has to be a fresh agreement for this new
use. Also, that this same condition will attach if the resource is transferred to third parties.
This may need to be bolstered by changes to the patent law as is being proposed by
developing countries at international fora. (This is discussed later in this paper.)
Invariably before a product is commercialized, a patent is sought. Developing countries at
the WTO have proposed changes to the TRIPS agreement to require patent applicants to
disclose the source of the derivative, the country of origin, the PIC and the MAT.
(c) 'AssociatedTK,18
(i) The value of TK
As with derivatives, the traditional knowledge of indigenous peoples and local
communities as to the use of the biological resource is what is of value to those seeking
access. TK leads researchers to select from amongst the great diversity of plants, animals
and microorganisms. It cuts down lead time by as much as a factor of 10. There are
numerous examples of this.19 In 1990, for example, the University of Florida patented a
Brazilian fungus known to be lethal to fire ants that can cause more than a billion dollars
in damage to US crops. The lead was provided by Brazilian farmers aware that something
in the soil kills fire ants. Three-quarters of plants that provide active ingredients for
prescription drugs came to the attention of researchers because of their use in traditional
medicine_2oAmong the 120 active compounds currently isolated from the higher plants
and widely used in modem medicine today, 75% show a positive correlation between
their modem therapeutic use and the traditional use of the plant from which they were
derived.
(ii) TK included in international fora discussions and regional ABS law
18 It has been suggested that 'information' is less ambiguous than 'knowledge' as there is no shared
understanding of the latter expression: The Crucible II Group: Seeding Solutions, vol 2, IDRC, IPGRI and
Dag Hammarskjold Foundation, 2001, at p. 14.
19 See further: Gurdial Singh Nijar, TraditionalKnowledge and Intellectual Property Interface: Responses,
policies and Options for Developing Countries, Centre of Excellence for Biodiversity Law, 2007,
(forthcoming publication).
20 Kloppenburg, J. Jr., 'No Hunting! Biodiversity, Indigenous Rights, and cientific Poaching', Cultural Survival
Quarterly, Summer 1991, P 15
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T~e .inclusion of TK, someti.me also desc~bed as 'intangible and immaterial property',
WIthin the scope of the CBD IS well recogruzed among developing countries in the TRIPS
debate on making the WTO mutually supportive with the CBD - of which more later.
Many regional developing country agreements include TK within the scope of their ABS
regimes: as inDecision 391 of the Andean Community on a Common Regime on Access
to Genetic Resources.i' the Organisation of African Unity Model La~2 and the ASEAN
Framework Agreement.r' The ASEAN Agreement makes clear that access to biological
or genetic resource does not automatically include access to the associated TK. Such
access must be explicitly indicated in the application for access."
TK in National Law25
An ABS national law will have to provide for the protection of TK. The governing
principles should be based on the recognition th~t:
TK and innovations are embedded inextricably in the cultural, social, spiritual and
economic practices and life of indigenous peoples and local communities. They
are generated in this context. Hence TK can only be protected in this contextual
form.
TK is a critical element of indigenous peoples and local communities' distinct ,
self-determined, self-identified cultural existence.
TK must be accorded protection in accordance with the criteria and custom and
practices established by the holders of TK;
TK must also be recognised as a holistic system. Any attempt to reduce it to some
component part useful for industry may ultimately lead to its fragmentation and
destruction. This could well undermine the cohesiveness of indigenous peoples
and local communities.
Indigenous peoples and local co~unities must be co~sulted and participate in all
decisions involving their TK. Their PIC must be obtamed and they must agree to
MAT; they must be able to refuse access or impose con~i~ions where appropriate,
such as where access is to their sacred or culturally sensitive knowledge or where
it would impinge affect their lifestyle and traditions - especially in relation to the
conservation and use of biological diversity.
The integrity of TK should be insulated from being undermined by IPRs .
•
•
•
•
•
•
21 See also Decision 486, Article 14. .' ..
22 Th Afri M d 1Legislation for the Protection of the Rights of Local Communities, Farmers and
e can oe '1 ical R
B d d f the Regulation of Access to BIO ogre esources.ree ers, an or d Fai dE itabl Shari fB fi ..
23 ASEAN Framework Agreement on Access to, an air an qui e an_ng 0 ene ts ansmg from
the Utilisation of Genetic and Biological Resources, Rev. 5 August 2004, Article 4(1) ..
24 Article 4(1).
25 further: G dial Singh Niiar TraditionalKnowledge and Intellectual Property Interface: Responses,
See er. ur ;J , • fE II f B' di .., d Opti fi Develoning CountrIes Centre 0 xce ence or 10 versity Law, 2006,
Policies an ptlOns or 'r '
(forthcoming publication).
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(d) Resources covered by the International Treaty on Plant Genetic Resources for
Food and Agriculture
This treaty, negotiated and concluded under the UN Food and Agricultural Organisation
(FAO), deals with plant genetic resources for food and agriculture (pGRF A)_26 It
establishes a multilateral system for access and benefit sharing of genetic resources for
food and agriculture as specified in a list in Annex I - consisting of 35 crops and crop
complexes and 29 forage species." The list can be expanded by consensus of the Parties
to the FAO. Not all crops on the list are automatically included in the multilateral system.
Only those crops for which some PGRF A are under the management and control of
the Contracting Parties and are in the public domain are included.28 Under Article 12
of the Treaty, the Parties agree to take the necessary legal or other appropriate measures
to provide facilitated access through the multilateral system to other contracting Parties
and to legal and natural persons under their jurisdiction. The Article sets out the terms
and conditions applicable for such access. These include the important condition that
access will be provided solely for the purpose of utilization and conservation for research,
breeding and training for food and agriculture.
Malaysia acceded to the Treaty on 5th May 2003. By ratifying the Treaty, a country
exercising its sovereign right to determine access to genetic resources in accordance with
Article 15 of the CBD, gives its general prior informed consent (PIC) to access to the
species listed in the annex of the Treaty. The mutually agreed terms (MAT) of such
access are those that will be set out in the standard material transfer agreement (MTA)
that has been developed by the Parties to the Treaty. Recipients of materials through this
multilateral system cannot claim IPR or other rights that limit facilitated access to
PGRF A or their genetic parts or components.
Hence a national law on ABS must state that
• The scope covers such of the listed plant genetic resources that Malaysia
declares to be under its management and control and are in the public
domain;
• The need for access approval, and the conditions for access.
• Access will be provided solely for the purpose of utilization and
conservation for research, breeding and training for food and agriculture;
• Access is subject to PIC as specified in national law ;
• The PIC for the access is deemed granted, on the terms set out in the
Treaty; and
26 It came into effect on June 2004.
27 Not included are some crops of great value to sustainable agriculture and food security such as: soya
bean, groundnut, many fruits and vegetables and tropical forages. Others that are not so widespread
include: African leafy vegetables which are potentially important as they provide nutritional well being of
the populace of many developing countries and regions.
28 Gerald Moore and Witold Tymowski, Explanatory Guide to the INPGR-FA, ruc 2005, at p. 15
(emphasis as in original). The ensuing di cussion is also based on this source.
• The benefit sharing arrangements are as set out in the MTA.
• No IPR or other rights can be claimed by the recipients of the gen ti
th
.. 29 e IC
resource or eir genetic parts or components.
• The genetic resources should not be given to third parties unless d
th Thi . I un erese .same terms. s me udes keeping these resources in the public
domam.
(e) Resources based on ownership: public or private
Where resources are on public land, the right of the State to regulate access to them is
clear. What if the genetic resource is on land that is privately owned? The land laws of
many countries extend ownership rights to whatever is on the land as well. Who will be
the provider of these resources? It is noted that the CBD gives countries the right to
regulate access to genetic resources on the basis that this belongs to the State.
(i) Options
There are three possible optionsr'"
First, that the proprietary rights to biological material only implies a non-exclusive right
to use the genetic resource.
Secondly, these proprietary rights to biological material only implies non-exclusive rights
to such material .
Thirdly, rights to genetic resources are separate from ownership over biological
resources. The private property rights to the biological materials are still respected but the
granting of rights to the genetic resources is left to national legislation.
(ii) TheAndean Communityposition
The Andean Community - Bolivia, Columbia, Ecuador, Peru and Venezuela - genetic
resources and derivatives are public property and inalienable. These resources can neither
be bought nor sold. There are no private property rights over the tangible or intangible
components of these resources.31 The resources are said to be the 'public patrimony of the
nation'.
29 Some proposals add the words: ... in theform receive~': Acce~s and Rights to Genetic Resources: a
NordicApproach, Nordic Council of Ministers & ~ordic council, 20~3, at p. 1.11. ..
30 Access and Rights to Genetic Resources: aNordic Approach, Nordic Council of Ministers & Nordic
council, 2003, at pp. 116-117. ."
31 Fernando Casas, 'Genetic Resources and. Property R.i~hts. Tangible and Intangible Property Rights. The
Issue of Derivatives', inRecord ofDisCllSSlOn, In:ematlOnal Expert Workshop on Access to Genetic
Re ources and Benefit Sharing, Cuemavaca, MeXICO,October 24-27, 2004, at p.178.
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In the Andean Community law scenario, the land owner's right to possession of a
resource is recognized where the resource is found on his land if he can establish that he
has been conserving the intrinsic value of biodiversity and the ecological, genetic, social,
economic, scientific, educational, cultural, recreational and aesthetic values of .the
resource. Once this right to possession is established, then the owner's PIC must be
obtained for access to the resource; and he is entitled to a share of the benefits. The
private owner/supplier of the resource must not undermine the national interest or
patrimony; and must comply with Decision 391 that regulates access to genetic resources
and derivatives. 32
This implies that the sovereign rights to the genetic resource lies with the State. However
the limited rights of owners of private lands where the resource is found are recognized.
They have the right to the non-exclusive use of the biological resource. As regards
indigenous peoples and local communities, there should be a presumption that they are in
possession of the resources in this sense. For others, if they can establish that they have
been conserving the intrinsic value of biodiversity and the values as outlined above, then:
• The owner's PIC must be obtained;
This cannot be unreasonably withheld given the right of the State to grant
access to genetic resources and derivatives within its jurisdiction;
• The owner is entitled to a fair share of the benefits.
(iii) National law options
A national law may consider the inclusion of the following scope:
• Biological resources, including genetic resources and their components, found in
in-situ conditions and their derivatives;
For purposes of access and benefit sharing:
• The PIC of the person in possession of the biological resource must be obtained;
• The PIC of indigenous peoples and local communities occupying/owning land
where the resource is to be accessed must be obtained;
• A definition of 'person in possession' (to consider the inclusion of some features
of the Andean Community formula).
• In any event the access and PIC of the State must be obtained in addition to the
PIC of the person in possession and indigenous peoples and local communities
invclved.v'
32 As in preceding footnote.
33 The Philippines' Executive Order 247 require the consent of both the government and the local
communities involved.
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(f) Based on the users of the resource: commercial or non-commercial (researchers in
public institutions)
Is there a basis for di~tinguishing between the various users of the resource? Inparticular,
should non-commercial researchers be exempted from the access provisions? Perhaps a
case can indeed be made out for exemption from the access provisions for this category
especially for work in public institutions. However this has to be carefully considered.
Where lies the boundary between the commercial and non-commercial research, and who
will draw this line?
The line between research for commercial purposes and no-commercial purposes is
blurring.l" It is not uncommon, especially in a developing country context, for the private
sector to fund public research with the expectation of commercializing the research result.
Or the research is jointly undertaken. In the US the Bayh-Dole Act of 1980 sought to
permit IP claims over outcomes of federally sponsored research. Universities and other
public research organizations responded by aggressively pursuing IPR protection to
generate revenue. The OECD promotes this model to turn 'Science into Business'r" This
kind of collaboration is also the avowed aim of most public universities in Malaysia.
(g) Exemptions from the scope
A national law may wish to specify what is, and who are, exempted from the scope of the
access requirements. This is not the same as saying that the subj ect matter is not within
the scope of the law.
One such exemption is the traditional uses of biological and genetic resources by
indigenous peoples and local communities in accordance with their customary practices
and traditions.
The other is the prohibition of human genetic resources from being the subject of access
applications. Technically human genes may qualify as genetic resources within the
meaning of the CBD. COP2 of th~ CB~ made it clear .that they were excluded.
Nonetheless it may be prudent to provide for Its express exclusion.
Both these exemptions are incorporated in Article 4 of the ASEAN Framework
Agreement.
34 S 1 R al Socl'ety Keening Science Open: The Effects of IP Policy on the Conduct of Scienceee examp e: oy ,r /d '
Lo d al S . ty 2003' www.royalsoc.ac.uklfiles/statfiles ocument-221.pdf.n on Roy ociety, . . IF Cl . . . ESRC C
3S Cited by Paul Oldham, Global Status ~nd Trends In alms: microorganisms, en~e for .
Economic and Social Aspects of GenoDllCS,2004, at p. 16-17.
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A State in the exercise of its sovereign rights will regulate access to all resources within
its territorial jurisdiction. This implies the need for an application for access. Any access
without permission will be illegal. An access infrastructure must be set up by national
law. There must be constituted a national competent authority to receive and process
applications. The role and functions of this authority will have to be delineated. Beyond
the usual role, it may be given additional functions even where it is not the owner of the
resource. This may include: to negotiate on behalf of the State or other parties, track
genetic resource use, collect and disburse fees and other benefits, enforce agreements and
coordinate collections and deal generally with all matters relating to the access. Other
matters may include the procedure for the applications; the right to appeal against any
refusal for access or the conditions imposed, and the penalties for unauthorized ...access.
2. ACCESS
(a) Applications for access: competent authority, powers, procedure for applications
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(b) Who is the authority to grant access: the country of origin?
As States have sovereign rights over their resources, they will have the power to grant
access. They will be the provider of the genetic resource. This refers to Parties to the
CBD that are the countries of origin of these resources; or countries who have acquired
the genetic resources in accordance with the CBD.
The expression 'country of origin is defined as ... the country which possesses those
genetic resources in in-situ conditions'. For species that are not domesticated or
cultivated, in-situ conditions are 'where genetic resources exist within ecosystems and
natural habitats'. This means the country where the resources are found naturally. For
domesticated or cultivated species the conditions are ' ... the surroundings where they
have developed their distinctive properties'. This will include a resource acquired from
another country, which then adapts, or is developed, to have a distinctly different genetic
make-up from the original genetic resource. So Malaysia will be the country of origin of
palm oil or rubber if these resources can be shown to have been developed over the years
by Malaysia and have developed genetic characteristics that are different from the
materials acquired historically from the source countries.
The other limb of the definition of 'country of origin' is a country that has acquired the
resource in accordance with the CBD. Treaties do not, as an accepted rule of
interpretation, have retrospective effect. 36 This means that the CBD only applies to
collections made after the coming into force of the CBD. Again, if the genetic material is
acquired contrary to the provisions of the CBD even after the coming into force of the
CBD, it will be excluded as it has not been acquired in accordance with the CBD.
36 Article 28, Vienna Convention on Treaties.
In respect of ~~sources on private lands or lands occupied by indigenous peoples and
local communities, there may also need to be an additional tier for consent as discussed
earlier.
(c) The obligation
The obligation under the CBD is to create conditions to facilitate access. This means no
more than putting in place a legislative or administrative regulatory framework that sets
out clear provisions as to how, and on what terms, access can be obtained.
(d) Imposing conditions for access
(i) For environmentally sound uses
The access can be made subject to conditions. First it should be for environmentally
sound uses: Article 12. This term is not defmed. It could mean adverse impacts to
biological diversity, centres of habitats, centres of origin, and traditional knowledge and
practices. Article 14(1)(a) of the CBD refers to 'procedures requiring environmental
impact assessment of ... proposed projects that are likely to have significant adverse
effects an biological diversity ... '.
(ii) No undue restrictions that may undermine CBD's objectives
Secondly, the word 'facilitate' suggests that there should be no undue and cumbersome
restrictions that would in effect undermine a genuine applicant. Inparticular, there should
not be any restrictions that undermine the objectives of the CBD. The objectives are
threefold:
• The conservation of biodiversity;
The sustainable use of its components;
And the fair and equitable sharing of the benefits arising from the utilization of
the genetic resources.
(iii) Denial if access may undermine CBD's objectives
•
•
Thirdly, and conversely, this also. means tha~ access may be le~itimately re~sed if it
results in any of the objectives bemg unde~ed. For example, If the collection of the
genetic resource could undermine ~e sustamabl~ .use of th~ ~on:ponents <biodiversity,
access may be denied or given subject to condIt:ons to mimnuze or aVOl?the adverse
impacts. This may also authorize ~ St.ate to require an asses.sment of the lI~pact of the
bio-prospecting on any of the objectives of the CBD. Article 14(1)(a), CIted earlier,
contemplates such impact assessments.
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The Andean Communities' law on access37 provides the following situations when access
may be partially or entirely refused:
• Endemism, rarity or danger of extinction of species, subspecies, varieties, or races
or breeds;
• Vulnerability or fragility of the structure or functioning of the ecosystems that
could worsen as a result of access-related activities;
• Adverse effects of access-related activities on human health or on elements
essential to the cultural identity of nations;
• Undesirable, or not easily controlled, environmental effects of access-related
activities on the ecosystems;
• Risk of genetic erosion caused by access-related activities;
• Regulations on biosafety, or on genetic resources and their derivatives or
geographic areas rated as strategic.
.
(iv) Access must be consistent with the sustainable use of the components of
biodiversity
Again access is for sustainable use of the components of biodiversity. The Andean
Community's list of situations when access may be refused includes that where access
may undermine sustainable use. According to a set of Guidelines developed by the IUCN
in developing the concept of 'sustainable use of the components of biodiversity', the use
of a particular species is likely to be sustainable if:
a. it does not reduce the future use potential of the target population or impair its
long term viability; .
b. it is compatible with the maintenance of the long term viability of supporting and
dependent ecosystems; and
c. it does not reduce the future use potential or impair the long term viability of other
species.
Other considerations that should be taken into account are avoiding wasteful use and
protecting animals from cruelty and avoidable suffering. Although the Guidelines are
primarily for wild species, they are considered holistic in nature as they cover species and
ecosystems. Thus Guideline (a) focuses on the impacts to the species being used.
Guidelines (b) and (c) weigh a particular species use against the impacts the use has on
ecosystems and other species_38
37 Decision 391, Article 45. Fernando Casas, 'Genetic Resources and Property Rights. Tangible and
Intangible Property Rights. The Issue of Derivatives', in Record of Discussion, International Expert
Workshop on Access to Genetic Resources and Benefit Sharing, Cuernavaca, Mexico, October 24-27,
2004, atp. 181.
38 Lyle Glowka and others, A Guideline to the Convention on Biological Diversity, WCN, 1994, at p. 57.
The Guidelines referred to are: Guidelines for the Ecological Sustainability of Non-consumptive and
Consumptive Uses of Wild Species.
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These Guidelines may be incorporated in national law to restrict or limit access.
(v) Otherconditions
Other conditions consistent with the objectives of the CBD may be imposed. These could
include, if there be any collection or other form of access, such conditions as a
declaration of: the purpose of the collection, the amount, the area, the duration, the
collaboration of nationals in the access activity, the anticipated benefits, the nature of the
rights to be claimed, what is to be done with the material or information accessed ,
whether research results will be shared, plans for cooperation with nationals in the R&D.
(e) Terms of the access
The CBD provides that access where granted shall be:
a. on mutually agreed terms (MAT): Article 15(4);
b. subject to the prior informed consent (PIC) of the provider country: Article 15(5);
and
c. on terms that include a fair and equitable sharing of the benefits: Article 15(7).
3. MUTUALLY AGREED TERMS - MAT
The law must establish the procedure for MAT. This will invariably be by agreement.
The state can leave parties to negotiate the terms as it is usual to expect that the provider
will be approached by a commercial entity for access. However there may be situations
where the resource provider (say a local community) is unmatched in terms of resources
and competence with a user (say a large company). In such a case, the law may prescribe
a standard MAT agreement Which contains the essential minimum safeguards. Or require
the intervening guiding hand of the State through the designated competent authority.
The State would be the primary party where it owns the resources. Where others are the
owners, MAT must be entered into with the holders of that resource as discussed earlier
as well as the State. There could be a tripartite agreement: the provider (State), the owner
and the applicant. Or, as an alternative there may be a provision for the State to review all
agreements and indicate its approval of the agreement. This may be necessary as the State
is ultimately responsible, at the international level, for ensuring that there is no breach of
its obligations under the CBD.
MAT should aenerally precede PIC. 'Informed' consent implies a full knowledge of the
access, its impact and the benefits. This suggests that PIC will only be given if the terms
are mutually acceptable and agreed upon. Indeed a MAT agreement can be more
appropriately merged within the PIC procedure.
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4. PRIOR INFORMED CONSENT - PIC
Prior informed consent will:
• require the applicant to obtain affirmative consent of the provider(s);
• be based on complete relevant information and full disclosure.
Again the provider whose consent must be obtained is to be determined by reference to
the ownership of the genetic resource. How this is determined, has been discussed earlier
in the context of the scope of a law on access. The law must stipulate the procedure for
obtaining PIC. The kind of information to be supplied that may have a bearing on
whether access should be given must also be stated. Such information could include: the
implications of the access, the nature of the genetic resource to be used - whether
tangible or not, the quantity of the resource to be accessed, how and by whom the
resource will be later used. -,
Unlike MAT, PIC is optional as made clear by the expression 'unless otherwise
determined by the Party' in Article 15(5) of the CBD. This means that a State must
affirmatively provide for this requirement, otherwise PIC is not required. Also, a State
has the option of excluding, or limiting the situations for, the PIC requirement in its law.
5. FAIR AND EQUITABLE SHARING OF BENEFITS
This requirement is interlinked with the first two. For only if MAT include fair and
equitable benefIt-sharing arrangements will PIC be given. Article 15(7) of the CBD
requires the sharing to be upon MAT. The sharing is of:
• The results of R&D; and
• The benefits arising from the commercial and other utilization of the genetic
resources accessed.
The paragraph refers to articles 16 and 19. This expands the coverage of the benefits to:
• Access to and transfer of technology using those resources including technology
protected by patents and other IPRs: Article 16(3);
• facilitated access to, joint development and transfer of technologies (including
biotechnologies) that are relevant to the conservation and sustainable use of.
biodiversity, or that makes use of genetic resources: Article 16(2) and (1);
• Participation in biotechnological research: Article 19(1); and
• Priority access to the results and benefits arising from biotechnologies using the
resource provided: Article 19(2).
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There are a range of possible benefits that can be negotiated in MAT. These could
include: monetary benefits such as upfront fees, royalties, advance payments, sample
fees, access to technology.
A law could simply state that fair and equitable benefits be provided for in a MAT. Then
it is for parties to negotiate the terms. The law could also go further and make some
benefits mandatory and others subject to agreement between the parties to MAT. For
example, if a country thinks it important to develop its technological base, the law could
require that all R&D activities must involve local participants and the results shared.
Also as the result of the use may not be known at the time MAT is negotiated, it will be
prudent for the law or the MAT to require that the use of the resource be declared; and
that if the use is other than the declared use, then the benefits are to be mutually
negotiated and agreed upon subsequently. This requires provisions that oblige the user to
keep the provider informed of the research and use of the genetic resource and its use for
a different subsequent purpose. The law may also provide for the PIC of the provider
before the resource is transferred to a third party. This will enable the negotiation of
MAT with the new party.
The law or MAT should also provide for: the potential benefits (including any IPRs), how
the benefits are to be distributed and who is to own the samples.
B. NATIONAL LAW: NEWPLANTVARIETIESACT2004
Malaysia has enacted a law on new plant varieties in 2004. This was in response to the
requirement in Article 27(3)(b) of TRIPS for members to provide for the protection of
plant varieties.
PIC
Applications for the registration of new plant varieties must:
• be accompanied with the written consent of the Iocal community or
indigenous people if the variety is developed from traditional varieties;
• give information relating to the source of the genetic material or the
immediate parental lines;
• give evidence of compliance of any law regulating access to genetic or
biological resources; and
• provide information that there has been compliance with any biosafety law
in cases where the variety involves genetic modification. .
The Act envisages the role of an ABS law as the application for a plant variety
registration (PBR) must also be supported by documents that comply with any law
dealing with access to genetic or biological resources. This provides an opening to ensure
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that appropriate benefits accrue to farmers and the country from the use of farmers' TK
and innovations in plant breeding. One of the objectives of the Act is to provide for the
'recognition and protection of (the) contribution made by farmers, local communities and
indigenous people towards the creation of new plant varieties' .
As the New Plant Varieties Act is already in force, this underlines the urgent imperative
for a comprehensive national law on ABS.
rr, lNTERNATIONAL DEVELOPMENTS
Developing countries are concerned that national measures are insufficient to stem the
biopiracy of their biological and genetic resources and associated TK primarily through
IPRs. They have made proposals to deal with this problem at international fora. A
national regime will have to consider whether the proposals will indeed reinforce national
ABS laws; and consider how to incorporate these in national legislation.
A. WTOfTRIPS
(a) The proposals of developing countries at the WTO/ TRIPS Council
In May 2006, nine developing countries presented a proposal to amend the TRIPS
Agreemenr'" - in particular Articles 27.3 and 29.40
The proposal requires any application for a patent to:
• disclose the source and country of origin of the genetic resources including
the TK used in the invention;
• provide evidence that the country of origin had consented to its extraction
and use; and
• furnish evidence of fair and equitable sharing of benefits under the
national regime.
These requirements must be stated in a certificate from the country of ongm
accompanying the application for a patent - known as 'a certificate of origin'.
39 Brazil, India, China Pakistan, Peru, Thailand and Tanzania. A revised version adds China and Cuba as
cosponsors. WT/GC/W/564.
40 The TRIPS Agreement is understood as permitting members to introduce an obligation to disclose the
origin of genetic resources and TK in patent applications. This proposal obliges members to introduce a
mandatory obligation. Hence the need for an amendment.
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(b) The rationale offered: need for international obligations to supplement national
regimes 41 .
Developing countries say that their proposals, if accepted, would implement TRIPS and
the CBD in a mutually supportive way. Also it would deal with the problem of biopiracy.
As bio-piracy transcends borders, they argue, it requires an effective global solution.
National laws requiring ABS and prior informed consent in their patent and other laws
has a limited territorial reach. National regimes have no control over resources acquired
from their country in respect of which patents claims are then made in another country
over that material or inventions deriving from that material. It is necessary then to have
universally binding provisions mandating countries to enforce measures against such
misappropriation through their national patent laws and to ensure that the provider
countries are not deprived benefits. Such binding requirements would supplement
measures in national regimes and ensure patent applicants comply with the laws and
practices of the countries of origin of the genetic resources including associated TK, in
accordance with the objectives and norms of the CBD.
A recent paper commissioned by the Secretariat of the CBD acknowledges the validity of
this argument. It states that while the CBD places the responsibility of ABS on both the
user and the source provider, yet the national legislation of both developed and
developing countries emphasises almost exclusively on access to the genetic resources of
the provider country. The paper notes that little relevant user laws have been adopted:
At present, developed country legislation does not appear to address the separate
requirement of the adoption of legislation or other measures with the aim of
sharing in afair and equitable way ... the benefits arising from the commercial
and other utilization of genetic resources as required in Article 15. 7. It is
certainly perceived not to support any attempt to enforce ABS requirements of
source countries. Claimants seeking remedies or enforcement of ABS principles in
these countries, would be forced to use basic provisions of contract and property
law, which evolved centuries before any concept of genetic resources as property,
and which do notprovide any legal basisfor ABS actions ,.42
So far the response to the proposals from the developed countries has been mixed. The
US, in particular, sees no conflict between the CBD and TRIPS, and argues that CBD
obligations can be satisfied by taking action at the national level, without the need for
action to be taken on the patent system or at the WTO. The US argues that these
41For a background to the emergence of these p~oposals .see: <;iurdialSingh ~ijar, Leg~l Issues and
Frameworks relating to Access and Benefit ~harmg ofBIOl~g1CalResources inMalays~a: ~urre~t status and
future needs, pending publication in Proceedings of the National ~oru:erence.~nAgrobiodiversity
Conservation and Sustainable Utilisation, 2007; see further, Gurdial Singh Nijar, TraditionalKnowledge
and Intellectual Property Interface: Responses, P~licies a~d C!ptionsfor Developing Countries, Centre of
Excellence for Biodiversity Law, 2007, (forthcommg publication).
42 UNEPICBDIWG-ABS/4/INF/6, WCN-Canada, Analysis of Claims of 'Unauthorised Access and
Misappropriation of GeneticResources and Associated TK', WCN-Canada, 2005, at p. 28.
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requirements are extraneous to the criteria for establishing the grant or refusal for a patent
- namely, that the patent is new, involves an inventive step and has industrial utility.
The European Union is prepared to consider the proposals of the developing countries but
only as a basis for discussion. It does not agree with the proposals requiring disclosure of
evidence of prior informed consent and benefit sharing. It is also against any form of
penalties under patent law. In other words, it agrees only with the disclosure of the
country of origin.
A large number of countries support the continued discussion on disclosure, and are
agreeable to the suggestion that the future meeting discuss the form and content of the
proposals.Y
These negotiations need to be closely monitored. If the amendments are carried, then
these will have to be reflected in the national law on ABS. There may also be a need then
to amend the national patent law to impose conditions for the processing of patent
applications.
B. CBD: ESTABLISHING AN INTERNATIONAL REGIME ON ACCESS AND BENEFIT SHARING
CABS)
-
Yet another development that has to be closely monitored is the negotiations for an
international regime on access and benefit sharing. This is being sponsored by developing
countries to bolster national ABS laws. This is premised on the view that the PIC, MAT
and the benefit-sharing provisions in Article 15 would not be effective unless there are
binding international measures to ensure that access is in compliance with the national
law of the provider country; and that there is a fair and equitable sharing of benefits of the
commercialization and utilization of the resource.
1. COP 7 DECISION; WORKING GROUP; COP 8 DECISION
On the basis primarily of the exhortations by the World Summit and the UN General
Assembly resolution.l" the 7th meeting of the Conference of the Parties in Kuala Lumpur
in 2004 - COP7 - set in motion negotiations for an International Regime (IR) on access
and benefit sharing of genetic resources. It established a Working Group and agreed on
the terms of reference. The scope of the potential IR includes access, and promoting and
safeguarding of fair and equitable sharing of benefits in accordance with the CBD
provisions; also included within the scope are: TK, innovations and practices in
accordance with Article 80) of the CBD. Among the elements in the terms of reference
43 The Report of the last TRIPS Council of the WTO agreed that the 'work (on the relationship between the
TRIPS and the CBD) continue on the basis of para 19 of the 2001 DOHA Ministerial Declaration and the
progress made in the Council for TRIPS todate,: S. Shashikant, 'TRIPS transition period for LDCs
extended by 7.5 years with conditions', Third World Economics, TWN, issue 368,1-15 Jan 2006,21 at 22.
44 For details see gurdial singh ijar, footnote 41.
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are: measures to ensure the prior informed consent of indigenous and local communities
holding TK associated with genetic resources; internationally recognized certificates of
origin/source/legal provenance of genetic resources and associated TK; disclosure of
origin/source/legal provenance of these in applications for IPRs; and the recognition and
protection of the rights of indigenous and local communities over their TK associated
with genetic resources and 'subject to national legislation' .
COP8 held in Brazil in March 2006, agreed to continue negotiations on the IR on the
primary basis of a text produced by the working group at Granada. The next round of
negotiations is scheduled for 10 - 14 September 2007 and will be followed immediately
by a meeting of the Article 80) WG. It is agreed that the negotiations be concluded 'as
soon as possible and in any event no later than COP 10 scheduled for 2010'.
These negotiations will have to be closely monitored as a national ABS law will have to
take into account the terms of an IR.
(a) Disclosure requirements
The COP8 decision highlights, as a possible measure for the development of the
international regime, the disclosure of origin/source/legal provenance of genetic
resources in IPR applications in national jurisdictions, in accordance with Art 16(5) of the
CBD. It was decided that a group of technical experts be nominated. They are to meet
and prepare a report on the form, intent and functioning of an internationally recognized
certificate of originlsource/legal provenance. The group is to look at the usefulness of the
certificate in fulfilling the objectives of the CBD, in particular Articles 15 and 80). The
issue of the desirability of this certificate is left open. The group is expected to meet on
22 - 25 January 2007.
(b) Cooperation with the Working Group (WG) on article 80)
Also to be closely watched is the work of the working group dealing with rights of TK of
indigenous and local communities.
COP7 has tasked this working group on Article 80) of the CBD to consider non-
intellectual-property based sui generis fo.rms ~f protection 0: TK; as wel~ as to deve~0Ps
elements for sui generis systems for TK listed ill an annex of some potential elements .
These include: recognition of elements of customary law relevant to the conservation and
sustainable use of biodiversity with respect to: customary rights in TK, biological
resources and customary procedures for access and consent to use TK, biological and
genetic resources; a process and set of requirements governing PIC, MAT and equitable
sharing of benefits with respect to TK; rights of TK h.olde~s and conditions for the grant
of the rights; the rights conferred; a system for the registration of TK and systems for the
4S Decision VWl6H inThe 2010 Biodiversity Target, Decisionsfrom COP7, UNEP,2004, p. 227, para 6.
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protection and preservation of TK; provisions for enforcement and remedies; relationship
to other laws, including international law; and, extra-territorial protection.
Through these 2 Working Groups, a clear basis has been established for developing
countries to press ahead with their agenda of establishing regimes at the international
level to deal comprehensively and effectively with the misappropriation of TK and GR as
well as provide for the sharing of benefits. And to ensure that the international regime
developed is consonant with the recognition and protection of TK. Central to these efforts
will be a satisfactory resolution of the interface between TK and IP. Realistically this will
only be possible if indigenous and local communities are actively involved in the
development of the regime.
C. WORLD INTELLECTUAL PROPERTY ORGANISATION -WIPO
Proposals similar to those suggested at the WTO/TRIPS have been introduced in WIPO
by developing countries. These are referred to as 'the development agenda. This includes
proposals for the protection of traditional knowledge, traditional cultural expressions
(folklore) and genetic resources. They are part of a multi-pronged approach in all fora
dealing with patents for a uniform stance with regard to effective international measures
to combat misappropriation. Negotiations over these proposals ended in a stalemate at the
last meeting of the intergovernmental committee held in June this year - 2006 - over
whether to address substantive legal text before completing work on objectives and
principles. The arguments for and against are much the same as in WTOITRIPS.46
ill. ISSUE: DISCLOSURE OF COUNTRY OF ORIGIN
There is concern amongst developing countries that including disclosure requirements for
patent applications will mean that they will have to disclose the country of origin from
where it originally took its genetic resources such as palm oil and rubber. They fear that it
may then have to fork out huge payments as benefits it has reaped through the
commercialization of these commodities.
It is submitted that this fear, with respect, is unfounded for the following reasons.
First, the amendments to make mandatory the disclosure requirements at the WTO are to
make the WTO provisions compatible with the CBD provisions relating to access and
benefit sharing of genetic resources and associated TK. More specifically it is to ensure
that the WTO does not undermine the access and benefit sharing provisions in article 15
of the CBD. The genetic resources in this article are confined to those that the Parties
have acquired 'in accordance with this Convention': Article 15.3 CBD. This will exclude
two distinct cases:
46 See earlier footnote 41.
L• Resources acquired prior to the Conventions' entry into force from the
provider of the resource; and
• Resources acquired illegally from the country of origin after the
Convention's entry into force.
The first case reflects the principle that international agreements do not have retroactive
effect. 47 This means that resources acquired before the CBD entered into force are
excluded from the reach of articles 15, 16 and 19. Hence no legal claims can be made by
Parties for benefit sharing."
Secondly, under the CBD, the country of origin regulates access rights and is entitled to
the benefits. 'Country of origin' is defmed as the country which possesses those genetic
resources in in-situ conditions, that is, within the country's ecosystems and habitats.
'Habitat' is defined as the place or type of site where an organism or population naturally
occurs.Y In the case of domesticated and cultivated species in-situ conditions means the
surroundings where the genetic resources have developed their distinctive properties.50
This refers to the country where the genetic resource has developed its distinctive
properties. 51 Where can a gene be said to have developed its distinctive properties?
Rubber and palm oil in Malaysia, for example, were brought from Brazil and Africa
respectively during colonial rule. Over the years these resources have been developed. I
have been advised that our palm oil and rubber since 1994 in any event, has acquired
distinctive properties. If this distinctiveness can be established, then Malaysia will be the
country of origin and is entitled to require other countries to disclose in patent
applications this fact and to prove they have PIC, MAT and benefit sharing arrangements
before their application for a patent will be processed or granted. Malaysia then stands to
reap the benefits.
Thirdly and, more importantly, countries from where the resource were first taken accept
the fact that the CBD does not cover these resources; as well as the fact that these
resources 'belong' to the country where they have developed distinctive features.52
Fourthly, the requirement for disclosure only applies in applications for patents. If no
such application is intended to be made, the disclosure provisions will not, in any event,
apply.
Fifth and fmally, the disclosure requirement in patent applications is a mechanism to
preve~t its ~au~orized ~se and e~sure the sharing of benefits. It does not apply where
there IS no intention to misappropriate the resource, and proper bilateral arrangements are
made for access and commercial use of the resource.
47 This is a principle of interpretation: see article 28 of the Vienna Convention.
48 Lyle Glowka et al, A Guide to the Convention on Biological Diversity, ruCN, 1994, pp. 77, 79.
49 Article 2 CBD.
50 Article 2 _ defining 'country of origin' and 'in-situ conditions'.
51 Lyle Glowka et al, A Guide to the Convention on Biological Diversity, ruCN, 1994, p. 18.
52 This is the position taken by the Group of Mega diverse Countries at the negotiations for the International
Regime beginning with the Working Group meeting in Bangkok in early 2005.
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IV. ABS AND IPRS
An ABS agreement needs to deal with the commercialization and IPR claims over the
product that uses genetic resources and associated TK. The disclosure requirements
sought by developing countries in international forums are to ensure mutually agreed
benefit-sharing arrangements between the provider and the applicant. Recently concluded
contracts in countries even without an ABS regime have addressed the issue of ownership
of the resource and the consequent benefit sharing arising from the commercialisation of
the product.
For example, Samoa recently concluded an agreement with the University of California
to isolate from an indigenous tree the gene for a promising anti-AIDS drug. The bark and
the stem-wood of the mamala tree naturally produces Prostatin. The discovery of its anti-
viral properties is based on traditional Samoan plant medicine. Traditional healers first
taught American ethnobotanists how to use the plant. It is intended to clone the genes and
insert them in bacteria to make microbial factories for the drug. The agreement
acknowledges sovereign rights in the gene sequence of Samoa. Fifty percent share of the
commercial proceeds from the genes will be allocated to the government, to villages and
to the family of the healers who gave the know how for extraction.
Ethiopia early this year (April 2006) concluded an agreement with a Netherlands
company, giving it exclusive access to an agreed list of Teff varieties to be used for
producing Teff-based food (flour and bread mix) and gluten-free beverage products (beer
and distilled products) and to develop new varieties of the plant more suitable for
producing such products. The company is not permitted to access the TK of the
communities on the conservation, cultivation and use of Tefl. It has agreed not to claim
any rights of such TK nor make any commercial benefits from it. The Ethiopian Institute
will inform the company of the existing TK that is relevant to the research proposed by
the company. This is to 'avoid possible confusion' between the TK of local communities
and inventions made by the company. The company has also agreed not to claim IPRs
over the genetic resources of Teff or over any component of the resources. But it is
allowed to obtain plant variety protection over the varieties it develops as co-owners with
the Ethiopian authorities. There is provision for non- monetary and monetary benefits,
including royalty payment of the profit from the sale of basic and certified seeds of the
Teffvarieties specified.
A similar agreement was entered into between Ethiopia and a UK Company with regard
to Vernonia - an annual industrial oilseed crop containing about 42% oil. Although the
company cannot claim IPRs over Vernonia or over any of its genetic components, it has
the right to obtain IPRs 'relating to inventions, products or applications developed using
Vernonia oil'. Other differences include: the company need not share the research results
if they affect the commercial advantage of the company. It is left to a future agreement to
specify what it is that affects the company's commercial advantage. The company is
described as having 'certain intellectual and industrial property right to a novel oil
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extraction and refining technological know-how potentially relevant to the development
of products derived from the oil' .53
An ABS law may include a provision specifying that the issue of IPRs be addressed and
considered. It could, for example, require the following to be considered: can IPRs be
claimed in respect of the genetic resource and associated knowledge, can such rights be
claimed for the innovation based on the resource and the knowledge, how are the benefits
to be shared on commercialization of the product/innovation?
This way benefit sharing may indeed be a strategy for rebalancing the current imbalances
in the IPR regime. 54
v. IMPLEMENTING THE ASEAN FRAMEWORK AGREEMENT ON ACCESS
TO, AND FAIR AND EQUITABLE SHARING OF BENEFITS ARISING FROM
THE UTILISATION OF, BIOLOGICAL AND GENETIC RESOURCES: AS
REVISED ON 5 AUGUST 2004
Malaysia and Indonesia along with 7 other countries are members of ASEAN. ASEAN
has finalised the final draft of the above agreement on 5 August 2004. No party has
signed the agreement as yet. The agreement comes into force 60 days after the 6th Party
ratifies the agreement. Singapore and Philippines have indicated their readiness to sign
the agreement.
Introduction
The agreement is almost a mirror image of the CBD. It recognizes the sovereignty of a
country over its biological and genetic resources and the right of a country to regulate
ABS. It provides a broad framework and makes it the responsibility of each country to
put in place such measures - legal, administrative or policy - for ABS; to establish
procedures for the grant of PIC, disseminate information on the status of access
applications; and to establish links with the regional clearing house.
The agreement leaves it to countries to formulate rules and procedures to implement
MAT and benefit-sharing. PIC is made mandatory and the agreement specifies the
minimum information that must accompany an application.
Some provisions have a regional dimension. The value of the agreement lies in this facet.
A clear objective of the agreement is to set minimum standards for ABS. This is to ensure
S3 For further information on the Ethiopian contract, see: Gurdial Singh Nijar, TraditionaiKnowledge and
Intellectual Property Interface: Responses, Policies and Options for Developing Countries, Centre of
Excellence for Biodiversity Law, 2006, (forthcoming publication).
54 Contra: Philippe Cullet, Intellectual Property Protection and Sustainable Development, Lexis Nexis-
Butterworths, 2005, at 183.
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that there is a regional minimum criteria for ABS. This will deter bioprospectors from
seeking the 'best' (least desirable - from the providers' point of view) terms for ABS.
This coupled with the requirement to inform the clearing house of all access applications
may help to reinforce a stronger regional framework. Again, the details of putting in
place regional measures and processes are left to be dealt with as part of the work after
the agreement comes into force.
We now look at the key features of this Agreement and the obligations that Malaysia will
have to adhere to after ratification.
1. The Preambular paragraphs: minimum standards on ABS, against biopiracy, IR
Most international or regional agreements start off with preambles. Although part of the
agreement, it is not the operative part of the agreement. Hence it is not binding. It
provides the background and the reason for the agreement. Preambles can be referred to,
to resolve any doubt in the main terms of the agreement.
In international agreements, they may sometimes reflect the more progressive thoughts
which could not be agreed to by consensus. They then may provide a road map as to the
future direction of the agreement.
An important preambular paragraph states that ABS are currently inadequately regulated
and thus the ( ...urgent need to protect the Parties interests especially from biopiracy or
illegal, unreported, unauthorized bioprospecting ,.55
The preambles also support the development of an international regime on ABS; and
declare the need to establish uniform and consistent access regulations in the region by
setting minimum requirements for national implementation to maximise opportunities for
conservation and sustainable use of biological and genetic resources.
2. Principles
Principles provide the general framework within which concrete obligations are framed.
Members must adhere to these tenets when implementing national legislation and
policies. The principles require Parties to
• ensure fair and equitable benefit-sharing at the community, national and regional
level;
55 A preambular paragraph in the initial 2000 Draft text stating as a fundamental principle that the prior
iriformed consent of the member tate and its indigenous peoples and local communities embodying
traditional lifestyles would have to be secured before access can take place is deleted from the present text.
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• recognize, respect and preserve and maintain TK of indigenous and local
communities;
• ensure PIC for access;
• facilitate exchange and utilization of food crop germplasm to enhance food
security in the region;
• consider the environmental and social impacts of access in conformity with
regional guidelines ..
The regional facets of the principles (the last 2 bullets) will impact a country's law.
There has to be some measures to facilitate germplasm exchange and utilization. And a
mechanism to ensure that due cognizance is taken of regional guidelines that give rise to
-environmental and social impacts of access.
'What is less clear is how and what benefits are to be shared at the regional level. This is
intended to apply to 'shared' resources that are endemic to the region; or where the
genetic resources or associated TK for the commercialization of a product is from
multiple member countries. The provision on benefit sharing makes reference to this in
terms that is not free from doubt, as we shall presently see.
3. Objectives
Objectives are similar to principles in that they provide the framework within which
actions have to be taken. It sets the basis for the specific obligations in the subsequent
articles. Implementation must conform to these objectives. The objectives also provide a
basis by which to monitor compliance.
One of the objectives is to accord recognition and protection to traditional knowledge of
indigenous peoples and local communities, and to facilitate the fair and equitable sharing
of benefits with the communities where traditional knowledge is utilized. Another is to
establish effective and participatory measures for the grant of prior informed consent,
'taking into account national perspectives and priorities'. And setting minimum standards
for ABS. The regional dimension is seen in the provisions that require cooperation to
facilitate access and to encourage sharing of resources, technologies, experiences and
information; and in encouraging R&D, adopting new technologies, promoting technology
transfer and capacity building at the regional level. There is also the objective of
cooperating to strengthen the voice of the parties in international agreements and
negotiations.
4. Scope
The agreement covers all biological and genetic resources of the Parties, including the
associated TK, with the exclusion of genetic resources of human origin. Access to
biological and genetic resources does not mean access to the TK associated with the
resource. Access to such TK must be expressly indicated in the application for access.
Derivatives are included in the scope as well, as the agreement requires the information
accompanying the PIC application to disclose benefits from derivatives and products
arising from the commercial and other utilization of the biological and genetic resources.
'Derivatives' is defined.
Indigenous and local communities are not to be prevented from the traditional uses of
biological and genetic resources in accordance with their customary practices and
traditions. They do not have to apply for access. All other individuals, agencies and
institutions must comply with access regulations established by the Parties.
5. Access Instrument
The nature of the access instrument will be determined by each Party's national policy
and legislation. It must incorporate the minimum terms and conditions prescribed by the
agreement.
6. Implementation
The agreement will be implemented by the Conference of the Parties.
7. Regional Clearing House Mechanism
A Regional Clearing House Mechanism will be established. Its responsibilities include:
• Providing relevant information to resource users and the competent national
authorities. The information will be subject to 'appropriate confidentiality'
provisions;
• Providing technical and legal support to competent national authorities;
• Establishing a database of biological and genetic resources and their
associated traditional knowledge· of the Parties, subject to national
arrangements;
8. Designating competent national authorities
The member States must designate their competent national authorities to fulfill the
obligations under the agreement.
9. Settlement of Disputes
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Any dispute between the Parties as to the interpretation or application of, or compliance
with, the agreement will be settled amicably by consultation or negotiation.
10. Prior Informed Consent and Participation of Key Stakeholders; Customary Law
The prior informed consent of the Party providing the biological and genetic resources is
necessary for access. The national competent authority must establish procedures for
securing the consent. The original 2000 draft required the competent national authority of
a State to establish legally-binding procedures for the determination of prior informed
consent up to the local level; and there were elaborate procedures prescribed leading to
the grant of prior informed consent at the local level. Also required was the 'active
involvement' of indigenous peoples and local communities embodying traditional
lifestyles. It also stipulated that the prior informed consent process must respect and
comply with the customary laws, practices and protocols of indigenous peoples and local
communities. And that the disclosure of any information relating to the access must be in
a language understandable to the local communities. These provisions have been deleted.
However, the essence of these earlier provisions is maintained. Now it is up to a Party to
establish procedures for the granting of prior informed consent at the national and local
levels with the direct involvement of resource providers.
The Parties must provide in their access regulations that any application for prior
informed consent must be accompanied by a full disclosure of the following information:
o legal entity and affiliation of the applicant and/or collector and
contact person when the entity is an institution;
o type and quantity of the resource to which access is sought;
o the period when the collection activities will take place;
o the geographical prospecting area;
o evaluation of how the access activity may impact on conservation
and sustainable use of biodiversity;
o information regarding intended use (example: taxonomy,
collection, research, commercialization and expected results;
o description of research and development methodology; and
o the typeslkinds of benefits and indication of benefit-sharing
arrangements that could come from obtaining access to biological
and genetic resources, including benefits from derivatives and
products arising from the commercial and other utilization of such
resources.
A provision in the 2000 draft that any denial of access by a Party will be notified to
others through the regional clearing house mechanism for their information and
appropriate action is deleted from the present text. There is nonetheless an obligation
to disseminate information on denials of access applications; as well as to provide
information to the regional clearing house. A reading of these provisions suggests that
information on denials of access will be provided to the clearing house. Additionally,
once such information, as well as that of the regulations, have been provided to the
clearing house, other Parties will be obliged to make sure those provisions and
decisions are not undermined. It follows that each Party's law and policy should
reflect the reciprocal recognition and enforcement of the decisions of other Parties.
11. Fair and Equitable Sharing of Benefits
'.
Each party is to establish processes to ensure the fair and equitable sharing of benefits
arising from the use of TK and resources: The earlier draft stated that any benefit sharing
arrangements must not 'negatively interfere' with traditional knowledge systems and
practices of indigenous peoples and local communities. This is deleted from the present
text. As is also deleted a provision that stated that member States must recognize the
indigenous peoples and local communities as legitimate users and custodians of
biological and genetic resources, and creators of TK. The present law in any event
implies these provisions. All resource providers.f must be 'actively' included in the
negotiation of benefits on the basis of a full disclosure of potential benefits and risks
arising from the use of the resource. such a provider is defined as persons or entities
supplying biological and genetic resources, including governments, local authorities, land
owners and bodies governing ex-situ collections.
The negotiation of the kind of benefit sharing arrangements that may come in the form of
technology transfer, capacity building, monetary and non-monetary benefits, is for the
State to decide. The earlier text listed a minimum set of requirements which must include
the following:
• The participation of nationals in research activities;
• The sharing of research results, including all discoveries;
• A complete set of all voucher specimens left in national institutions;
• Access by nationals to all national specimens deposited in international ex situ-
collections;
• The receipt by resource providers, without payment of a royalty of all
technologies developed from research on provided materials;
56 The earlier 2000 text specified in particular indigenous peoples and local communities embodying
traditional lifestyles. This is omitted from the pre ent text, although they are included in the generic term
'resource providers' .
• Fees, royalties and financial benefits; and
• The donation to nationalinstitutions of equipment used as part of research.
,
The omission of the minimum requirements means that Parties are free to enter into any
requirements it considers necessary.
If biological or genetic resources are indigenous to two or more Parties, then these parties
may collectively discuss with the bioprospector the terms and conditions of access and
benefit-sharing. The Parties may discuss the sharing among themselves of these benefits.
This provision is unclear. It gives rise to the following questions:
• Who is to decide that the resources exist in two or more parties' territories? /
• On whom lies the obligation to initiate the collective discussion?
As an example, if a company seeks a specific resource from Malaysia, must
Malaysia do a survey of which other countries of ASEAN the resource exists in?
Who is to inform of the collective discussion? Given that biological resources are
endemic to the region, this may involve a discussion of all the countries in the
group.
• Is the country where the resource exists entitled to share merely because the
resource grows in its territory?
• What if the access is to the knowledge in the resource and this knowledge is not
shared? country
• What will happen to any agreement entered into without taking into account these
provisions?
• How are the benefits to be apportioned?
12. Common Fund for Biodiversity Conservation
A Common Fund has been created for biodiversity conservation. Eliminated are the
elaborate provisions in the earlier draft which included money to be sourced from a share
in the revenues derived from any commercialization of the use of common and shared
resources among the member States; and from charges and fees from each access
application; as well as from the benefit-sharing arrangements negotiated by each Party.
The present text provides for voluntary contributions, and contributions from other
sources, including regional financial institutions and the international donor community.
The purpose and application of the Fund is not specified and will need to be spelt out in
follow-up rules or guidelines.
13. Environmental and Social Impact and Biosafety Concerns
The 2000 text required conformity with any national, regional and international
guidelines on biosafety. Prospects were also held out for a biosafety framework or
protocol to be developed by ASEAN'S Working Group on Nature Conservation and
Biodiversity or other relevant ASEAN bodies. This has been deleted. However, there is a
requirement to take into consideration the various environmental and social impacts of
access to genetic resources in conformity with national, regional and international
guidelines. Also there must be a full disclosure of potential benefits and risks arising from
the use if biological and genetic resources. This seems to include biosafety risks and
concerns.
14. A summary
Each Party must enact a national ABS law with the following provisions:
a. Scope: biological and genetic resources, derivatives and associated TK: Article
4(1), read with article 6(2)(h) and Article 2, definition of 'derivatives';
b. Exemptions from Scope: genetic resources of human origin: Article 4(1);
c. Exemptions from access application provisions: traditional uses of biological and
genetic resources and derivatives by indigenous and local communities ill
accordance with their customary practices and traditions: Article 4(3); .
d. Procedures for PIC: this shall include the direct involvement of resource
providers: Article Sea);
e. Disclosure in PIC applications of the information set out in paragraph 10 above:
Article 6(2);
f. MAT for benefit sharing arrangements: Article 7(1);
g. Inclusion of all resource providers in negotiations for MAT: Article 7(1);
h. Full disclosure of potential benefits and risks arising from the use of genetic
resources: Article 7(1);
1. Processes to ensure fair and equitable sharing of benefits from the use of TK and
resources: Article 7(2);
J. The nature of the benefits: Article 7(3);
k. Designation of competent authorities and focal points and related rules: Article
10.
It is noted that many of these requirements are similar to those that a country will adopt in
implementing the goals and provisions of the CBD.
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The Parties must at the regional level provide for the following:
a. The minimum standards of a national ABS law: preamble.
b. Mechanisms and provisions for benefit sharing at a regional level: Art 2(d).
c. Measures for the facilitation of exchange and utilization of food crop germplasm:
Article 2(£).
d. Identification of the national, regional and international guidelines on
environmental and social impacts of access to biological and genetic resources:
Article 2 (h).
e. Cooperative measures for facilitating access to these resources: Article 3(d).
f. Cooperative measures for the sharing of resources, technologies, experiences and
information: Article 3(d).
g. Cooperative measures for R&D, adoption of new technologies, technology
transfer and capacity building: Article 3(£).
h. Measures for stimulating sustainable use and development of biodiversity
endemic to the region: Article 3(h).
1. Set up a forum for intra-regional cooperation for international negotiations:
Article 3(i).
J. Cooperative efforts for a joint approach to protect against biopiracy, including at
the WTOITRIPS, WIPO, and the CBD: preamble, Article 3(i).
k. Mechanism for the dissemination of information on access regulations: Article
5ec).
1. Mechanism for the dissemination of information on status of access applications:
Article 5(c). '"
• l1.~!":.•
m. The process for dealing with applications and ABS where resources to be
accessed are indigenous to two or more Parties: Article 7(8).
,
n. Operational mechanism and rules for the Regional Clearing House: Article 11.
o. Rules for the purposes for, and manner of, application of the Common Fund for
Biodiversity Conservation: Article 12.
p. Dispute settlement rules of procedures: Article 13. ..'
VI. FREE TRADE AGREEMENTS
Many developing countries have signed, or like Malaysia, are negotiating, bilateral free
trade agreements (FTA). On the promise of growth of trade and economic development,
deals are being extracted. Some impose stringent commitments with regard to
investments and IPRs which may undermine the international gains obtained in the CBD.
Some lessons for vigilance can be learnt from the experiences of FTAs concluded by
other developing countries.
(a) Peru-US FTA
Peru, for example, recently entered into an FTA with the US. According to a recent study
by GRADE, a Lima-based public policy research institute, poor indigenous fanners will
be affected by the IPR commitments that now legalize the patenting of genetic resources
and traditional knowledge. 57 The FTA disregards Peru's commitment to Andean law
which, as we noted earlier, outlaws the patenting of plants. The Peru-US FTA accepts the
US demand to "make all reasonable efforts" to start patenting plants and to never go back
on this policy once in place.
Nor does the US-Peru FTA obligate the US patent office to require applicants seeking
plant patents to include "disclosure requirements." This is again contrary to the Andean
regional agreement which requires applicants to declare where they got their materials or
knowledge from, prove that they received permission to use them, and make
arrangements to share benefits with their original owners.
(b) Economic Partnership Agreement between Eastern and Southern Africa and the European
Community58
Another example is the Economic Partnership Agreement (EPA) being negotiated
between the European Union and six regional blocs of African, Caribbean and Pacific
Island states pursuant to the Cotonou Agreement of 2000. Negotiations on these EPAs are
supposed to conclude before 31 December 2007, for entry into force on 1 January 2008.
The EPAs are free trade agreements (F'I'As) aiming to liberalise the economies of former
European colonies through a package of direct commitments to, and assistance from, the
EU.
57 IntiMontenegro de Wit, 'FTA Means Deeper Poverty In Peru' 2006, www.twnside.org ..
58 Title VI - Intellectual property rights, ref: 4th Draft EPA/8th RNFI24-8-2006!, 24 August 2006
Full text of the draft EPA at htij?:IIBTWW.bilateral.org'article.ptw3?id article 6014
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A recent draft of the EPA with the 16 Eastern and Southern Africa countries deals with
rights to local biodiversity and traditional knowledge. The chapter on intellectual
property rights endorses the patenting of genetic material, including human genes, and
indigenous knowledge from Africa by European companies through a consent-and-
compensation procedure. This is meant to "protect" Africa from "biopiracy". If agreed to,
patenting life would be acceptable. African countries have fought long and hard against
this principle and, as we noted earlier, the African Union model law prohibits patents on
life.
The EPA draft also frames rights to African biodiversity and traditional knowledge as
"intellectual property". 59 The proposal extends this interpretation, for the governments
that sign it,.to the concept of Farmers' Rights under the FAO International Treaty on Plant
Genetic Resources for Food and Agriculture.
This effectively undermines TK and the national law and policy options already adopted
or agreed to by these countries. The process for these far reaching potential changes has
been questioned. An international non-governmental organisation, GRAIN, states,
rhetorically, widely held concerns:
Farmers' rights a trade issue? Traditional knowledge to be bought and sold as
IPR? Patents on life ok, as long as you pay? And all of this hammered out behind
closed doors, far away from the rural communities who are the stewards of
Africa's biodiversity and stand nothing to gain from it being sold off to European
corporations as intellectual property!
This suggests the urgent need to repudiate the strictures of the requirements of these
FTAs as incompatible with the interests of developing countries - especially as they
require a roll back of the laws and policies of these countries; and impose restrictions that
are more onerous than the multilateral WTO agreement on these issues. They deny the
flexibilities that TRIPS allows for countries to shape laws to suit their stage of
development. Such breathing space is conspicuously missing from these North-South
FTAs.
59All orth- outh FTAs dealing with traditional knowledge provide for this: see Briefings by GRAIN, 26
ept 2006.
vn. A CHECKLIST
A checklist of a national ABS agreement consistent with the CBD and the ASEAN
Framework law
Such an agreement should consider including the following:
• Authority: an authority designated by the State to deal with all matters relating to
access to biological resources;
• Approval: Access only if there is approval by this authority;
• Scope: the resource(s) to be covered in the scope of the law. Includes both
biological and genetic resource (ASEAN). The scope also extends to associated
TK (ASEAN). To consider whether scope should: .
• include derivatives;
• have separate consideration for resources based on ownership:
public or private;
• have separate considerations based on the users of the resource:
commercial or non-commercial (researchers in public institutions)?
• The information to be supplied in all applications for access including: an
assessment of the impact on environment; on sustainable use; and on TK and
indigenous peoples and local communities; [possibly at regional level- see later];
• Access applications for TK distinct from applications for access to biological and
genetic resources(ASEAN);
• Disseminating information: on access regulation, applications for access that have
been approved and denied - including the reasons and circumstances for the
denial (ASEAN);
• PIC at the local and national levels with the direct involvement of the resource
providers and associated procedures (ASEAN);
• PIC applications must disclose:
o legal entity and affiliation of the applicant and/or collector and
contact person when the entity is an institution;
o type and quantity of the resource to which access is sought;
o the period when the collection activities will take place;
o the geographical prospecting area;
o evaluation of how the access activity may impact on conservation
and sustainable use of biodiversity;
o information regarding intended use (example: taxonomy,
collection, research, commercialization and expected results;
o description of research and development methodology; and
o the types/kinds of benefits and indication of benefit-sharing
arrangements that could come from obtaining access to biological
and genetic resources, including benefits from derivatives and
products arising from the commercial and other utilization of such
resources.
• MAT: its contents and procedures;
• A prescription of the benefits and the manner of sharing, including criteria for
ascertaining 'fair and equitable';
• Whether to prescribe processing fee and other upfront payments;
• Restrictions for considering access based on the objectives of the CBD;
• Exemptions from access application by indigenous and local communities for
traditional uses of biological and genetic resources in accordance with their
customary practices and traditions (ASEAN).
• , Other general restrictions including those on future use such as limits on the
amount and manner of collecting, on third party use and transfer and
specifications for environmentally sound uses;
• Whether user to provide periodic reports on subsequent use of the resource; also
procedure associated with the report - form, frequency and receiving authority;
• IPRs: who to own, what resource (genetic and associated knowledge, innovation),
requirement in applications for IPR for disclosure of compliance with national law
(that PIC, MAT and benefit-sharing provisions complied with);
• Research collaboration and sharing of results;
• Export restrictions;
• Biosafety restrictions to ensure the safe exchange of genetic resources;
• An appeal process where access denied or applicant unhappy with the conditions
imposed;
• Access given for free or.at a minimal cost to the crops listed in Annex 1 of the
ITPGRFA if these are 'declared to be in the public domain and under the
management and control of the Parties.60 Access should be for free or at a
minimal cost. There can be no lPR or other rights claimed that could limit the
facilitated access to the genetic resource or their genetic parts or components 'in
the form received by the multilateral system;
• Benefit sharing of crops in the preceding bullet on the basis of the standard MTA
under the ITPGRFA.
60 This includes Annex 1 materials held in the ex situ collections of the Future Harvest Centres. The treaty
states that the Centres' non-Annex 1 materials will be made under substantially the same conditions.
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• Regional - amongst Parties to the ASEAN Agreement: cooperation, R&D,
sharing of benefits where resources in product from regional source; transfer of
technology, development of new technologies, sharing of resources (including the
exchange of germplasm), technologies, experiences and information, consider
environmental and social impacts of access to Parties; and ensuring that the
legislative, administrative and policy measures of each Party in implementing the
agreement are not undermined; providing information to the regional clearing
house.
• Regional: provision for collective determination of the terms and conditions of
access and benefit-sharing with the applicant, where biological or genetic
resources are indigenous to two or more Parties. This includes determining how
the benefits are to be apportioned (ASEAN).
• Regional: provision to authorize the voluntary contribution to the ASEAN
Common Fund doe Biodiversity Conservation .
. Note: The regional obligations could be the subject of a separate instrument designed
to deal specifically with the regional facets of the ASEAN Framework agreement.
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